TY - JOUR
T1 - Research gaps in pancreatic cancer research and comparative effectiveness research methodologies
AU - In, Haejin
AU - Posner, Mitchell C.
N1 - Publisher Copyright:
© Springer International Publishing Switzerland 2015.
PY - 2015
Y1 - 2015
N2 - Despite advances in cancer care, pancreatic adenocarcinoma remains one of the most lethal tumors. Most patients with pancreatic cancer are diagnosed with late stage disease, and approximately 6 % of patients are alive 5 years after diagnosis. Of the 10–20 % of patients who are candidates for resection and multi-modality therapy, most will succumb to the disease with 5-year survival rates only reaching approximately 25 % (Lim et al. in Annals of surgery 237(1):74–85, 2003 [1]; Trede et al. in Annals of surgery 211(4):447–458, 1990 [2]; Crist et al. in Annals of surgery 206(3):358–365, 1987 [3]). Clearly, there is a need to improve the management of this disease. To identify gaps in research and formulate strategies to address these issues, we designed a framework to encompass the scope of research for pancreatic cancer. In this chapter, we will examine each topic heading within this framework for gaps in knowledge and present research strategies focusing on diverse comparative effectiveness research (CER) methodologies to address the identified gaps.
AB - Despite advances in cancer care, pancreatic adenocarcinoma remains one of the most lethal tumors. Most patients with pancreatic cancer are diagnosed with late stage disease, and approximately 6 % of patients are alive 5 years after diagnosis. Of the 10–20 % of patients who are candidates for resection and multi-modality therapy, most will succumb to the disease with 5-year survival rates only reaching approximately 25 % (Lim et al. in Annals of surgery 237(1):74–85, 2003 [1]; Trede et al. in Annals of surgery 211(4):447–458, 1990 [2]; Crist et al. in Annals of surgery 206(3):358–365, 1987 [3]). Clearly, there is a need to improve the management of this disease. To identify gaps in research and formulate strategies to address these issues, we designed a framework to encompass the scope of research for pancreatic cancer. In this chapter, we will examine each topic heading within this framework for gaps in knowledge and present research strategies focusing on diverse comparative effectiveness research (CER) methodologies to address the identified gaps.
KW - Adaptive clinical trials
KW - Big data
KW - Comparative effectiveness research
KW - Databases
KW - Expertise-based clinical trials
KW - Pancreatic cancer research
KW - Pancreatic cancer treatment
KW - Tumor registries
UR - http://www.scopus.com/inward/record.url?scp=84923344019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923344019&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-12553-4_10
DO - 10.1007/978-3-319-12553-4_10
M3 - Article
C2 - 25677024
AN - SCOPUS:84923344019
SN - 0927-3042
VL - 164
SP - 165
EP - 194
JO - Cancer treatment and research
JF - Cancer treatment and research
ER -